Preferred Label : ALN-PCSsc;
Origin ID : M000626058;
ATC code(s)
- CISMeF manual mappings
- Currated CISMeF NLP mapping
- Related record
- ALN-PCS [MeSH Supplementary Concept]
https://www.has-sante.fr/jcms/p_3538269/fr/leqvio-inclisiran-dyslipidemie
2024
false
false
false
France
leqvio
primary prevention
insurance, health, reimbursement
treatment outcome
hypercholesterolemia
Familial hypercholesterolemia - heterozygous (disorder)
adult
inclisiran
drug antagonism
rna, small interfering
injections, subcutaneous
evaluation of the transparency committee
ALN-PCSsc
---
https://www.ema.europa.eu/en/medicines/human/EPAR/leqvio
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
ALN-PCSsc
ALN-PCSsc
inclisiran
hypercholesterolemia
Primary hypercholesterolemia (disorder)
mixed dyslipidemia
drug therapy, combination
injections, subcutaneous
Proprotein Convertase 9
product surveillance, postmarketing
hypolipidemic agents
hypolipidemic agents
adult
aged
pregnancy
breast feeding
drug evaluation, preclinical
ALN-PCS
ALN-PCS
rna, small interfering
rna, small interfering
---
https://www.cadth.ca/fr/inclisiran
2021
false
false
false
Canada
French
ALN-PCSsc
Inclisiran
inclisiran
hypercholesterolemia
Primary hypercholesterolemia (disorder)
drug information
insurance, health, reimbursement
ALN-PCS
rna, small interfering
---
https://www.cadth.ca/fr/linclisiran-petit-arn-interferent-pour-traiter-lhypercholesterolemie
2019
false
false
false
Canada
French
ALN-PCSsc
drug information
inclisiran
hypercholesterolemia
rna, small interfering
anticholesteremic agents
ALN-PCS
---
